Economic evaluations in rheumatoid arthritis: a critical review of measures used to define health States. (Q37144969)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18429656%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

review article

1 reference

title

Economic evaluations in rheumatoid arthritis: a critical review of measures used to define health States (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18429656%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18429656%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Jonathan Karnon

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18429656%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

author name string

Roberta Ara

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18429656%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Aslam Anis

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18429656%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18429656%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18429656%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18429656%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18429656%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

395-408

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18429656%20AND%20SRC:MED&resulttype=core&format=json

The impact of functional status and change in functional status on mortality over 18 years among persons with rheumatoid arthritis.

6 January 2020

cites work

1 reference

12 December 2020

Cost effectiveness of adalimumab in the treatment of patients with moderate to severe rheumatoid arthritis in Sweden

1 reference

12 December 2020

Rheumatoid arthritis: direct and indirect costs

1 reference

12 December 2020

Cost effectiveness of etanercept (Enbrel) in combination with methotrexate in the treatment of active rheumatoid arthritis based on the TEMPO trial

1 reference

12 December 2020

The costs of rheumatoid arthritis: an international long-term view

1 reference

12 December 2020

Should improvement in rheumatoid arthritis clinical trials be defined as fifty percent or seventy percent improvement in core set measures, rather than twenty percent?

1 reference

12 December 2020

Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

1 reference

12 December 2020

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

1 reference

12 December 2020

Modeling the 5-year cost effectiveness of treatment strategies including tumor necrosis factor-blocking agents and leflunomide for treating rheumatoid arthritis in the Netherlands

1 reference

12 December 2020

The dimensions of health outcomes: the health assessment questionnaire, disability and pain scales

1 reference

12 December 2020

A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness

1 reference

12 December 2020

Association between etanercept use and employment outcomes among patients with rheumatoid arthritis

1 reference

12 December 2020

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis

1 reference

12 December 2020

The case of tumour necrosis factor-alpha inhibitors in the treatment of rheumatoid arthritis: a budget impact analysis.

1 reference

12 December 2020

Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score

1 reference

12 December 2020

A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis

1 reference

12 December 2020

Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis.

1 reference

12 December 2020

Minimum important difference between patients with rheumatoid arthritis: the patient's perspective

1 reference

12 December 2020

TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden

1 reference

12 December 2020

Using the health assessment questionnaire to estimate preference-based single indices in patients with rheumatoid arthritis

1 reference

12 December 2020

Modeling and cost-effectiveness analysis of etanercept in adults with rheumatoid arthritis in Japan: a preliminary analysis.

1 reference

12 December 2020

Direct medical costs and their predictors in patients with rheumatoid arthritis: a three-year study of 7,527 patients

1 reference

12 December 2020

Therapeutic strategies for rheumatoid arthritis

1 reference

12 December 2020

Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study

1 reference

12 December 2020

1 reference

12 December 2020

Cost effectiveness of tumour necrosis factor-alpha inhibitors as first-line agents in rheumatoid arthritis

1 reference

12 December 2020

The clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a systematic review and economic analysis

1 reference

12 December 2020

An overview of economic evaluations for drugs used in rheumatoid arthritis : focus on tumour necrosis factor-alpha antagonists

1 reference

12 December 2020

Biologic therapies on the horizon for rheumatoid arthritis

1 reference

12 December 2020

Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis

1 reference

12 December 2020

An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline

1 reference

12 December 2020

The 'side effects' of rheumatoid arthritis: joint destruction, disability and early mortality

1 reference

12 December 2020

A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis

1 reference

12 December 2020

The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation.

1 reference

12 December 2020

Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany: II. The contribution of leflunomide to efficiency

1 reference

12 December 2020

Modelling the costs and effects of leflunomide in rheumatoid arthritis

1 reference

12 December 2020

Predicting mortality in patients with rheumatoid arthritis

1 reference

12 December 2020

Links between radiological change, disability, and pathology in rheumatoid arthritis

1 reference

12 December 2020

Determining minimally important changes in generic and disease-specific health-related quality of life questionnaires in clinical trials of rheumatoid arthritis

1 reference

12 December 2020

Joint damage and disability in rheumatoid arthritis: an updated systematic review

1 reference

12 December 2020

Not all "quality-adjusted life years" are equal.

1 reference

12 December 2020

The cost effectiveness of infliximab for severe treatment-resistant rheumatoid arthritis in the UK.

1 reference

12 December 2020

Epidemiology and burden of illness of rheumatoid arthritis

1 reference

12 December 2020

The long-term outcomes of rheumatoid arthritis: a 23-year prospective, longitudinal study of total joint replacement and its predictors in 1,600 patients with rheumatoid arthritis

1 reference

12 December 2020

The horseless carriage: moving forward with the hybrid ACR

1 reference

12 December 2020

A multicenter cost-of-illness study on rheumatoid arthritis in Italy

1 reference

12 December 2020

The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century

1 reference

12 December 2020

Systematic review of studies of productivity loss due to rheumatoid arthritis

1 reference

12 December 2020

The effect of including C-reactive protein in cardiovascular risk prediction models for women.

1 reference

12 December 2020

Modelling the cost effectiveness of TNF- antagonists in the management of rheumatoid arthritis: results from the British Society for Rheumatology Biologics Registry

1 reference

12 December 2020

The economic cost and social and psychological impact of musculoskeletal conditions. National Arthritis Data Work Groups.

1 reference

12 December 2020

Estimating the cost-effectiveness of 54 weeks of infliximab for rheumatoid arthritis

1 reference

12 December 2020

Cost-effectiveness analysis of biological treatments for rheumatoid arthritis

1 reference

12 December 2020

Measuring preference weights for American college of rheumatology response criteria for patients with rheumatoid arthritis.

1 reference

12 December 2020

A cost-effectiveness analysis of treatment options for patients with methotrexate-resistant rheumatoid arthritis

1 reference

12 December 2020

Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumati

1 reference

12 December 2020

Economic consequences of the progression of rheumatoid arthritis in Sweden

1 reference

12 December 2020

Early functional disability predicts both all-cause and cardiovascular mortality in people with inflammatory polyarthritis: results from the Norfolk Arthritis Register.

1 reference

12 December 2020

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials

1 reference

12 December 2020

Responsiveness of the core set, response criteria, and utilities in early rheumatoid arthritis

1 reference

12 December 2020

The cost-effectiveness of infliximab (Remicade) in the treatment of rheumatoid arthritis in Sweden and the United Kingdom based on the ATTRACT study

1 reference

12 December 2020

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.

1 reference

12 December 2020

A critique and impact analysis of decision modeling assumptions

1 reference

12 December 2020

Measuring function in rheumatoid arthritis: Identifying reversible and irreversible components

1 reference

12 December 2020

The initial validation of a Markov model for the economic evaluation of (new) treatments for rheumatoid arthritis

1 reference

12 December 2020

Cost-effectiveness of letrozole, anastrozole and exemestane for early adjuvant breast cancer

1 reference

12 December 2020

Biologic drugs for rheumatoid arthritis in the medicare program: A cost-effectiveness analysis

1 reference

12 December 2020

Analytic choices in economic models of treatments for rheumatoid arthritis: What makes a difference?

1 reference

12 December 2020

Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK.

1 reference

12 December 2020

10.2165/00019053-200826050-00004

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18429656%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 January 2020

1034007818

0 references

Fatcat ID

release_pddg7mn2bba5bduhmffi6lej3i

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pddg7mn2bba5bduhmffi6lej3i

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18429656%20AND%20SRC:MED&resulttype=core&format=json